Annual medical expenditure (2020 US$) and average HbA1c values before and after the diagnosis of type 2 diabetes estimated from the panel linear regression with fixed effects
Total medical expenditure, 2020 US$ (n=83 526) | Average HbA1c, mmol/mol (n=34 533) | |||||
Variable | Coefficient | SE | P value | Coefficient | SE | P value |
Time | ||||||
−10 | −$8644 | $674 | <0.0001 | −12.18 | 1.17 | <0.0001 |
−9 | −$8509 | $584 | <0.0001 | −7.64 | 0.98 | <0.0001 |
−8 | −$8461 | $524 | <0.0001 | −8.51 | 0.65 | <0.0001 |
−7 | −$7745 | $483 | <0.0001 | −7.74 | 0.49 | <0.0001 |
−6 | −$8027 | $449 | <0.0001 | −7.06 | 0.36 | <0.0001 |
−5 | −$7027 | $421 | <0.0001 | −6.63 | 0.29 | <0.0001 |
−4 | −$7061 | $396 | <0.0001 | −6.13 | 0.23 | <0.0001 |
−3 | −$6696 | $372 | <0.0001 | −5.73 | 0.18 | <0.0001 |
−2 | −$6419 | $350 | <0.0001 | −4.88 | 0.15 | <0.0001 |
−1 | −$5781 | $348 | <0.0001 | −3.49 | 0.13 | <0.0001 |
0 | ||||||
1 | −$3160 | $345 | <0.0001 | −2.00 | 0.12 | <0.0001 |
2 | −$2491 | $374 | <0.0001 | −1.61 | 0.14 | <0.0001 |
High cost | ||||||
Cancer | $9146 | $346 | <0.0001 | −0.15 | 0.16 | 0.3781 |
HIV/AIDS | $6257 | $3418 | 0.0672 | −0.66 | 1.60 | 0.6803 |
Childbirth | $15 797 | $1147 | <0.0001 | −2.78 | 0.64 | <0.0001 |
Comorbidities | ||||||
Hypertension | $6065 | $276 | <0.0001 | −0.14 | 0.15 | 0.3408 |
Hyperlipidemia | $579 | $244 | 0.0179 | −0.11 | 0.13 | 0.4095 |
Chronic obstructive pulmonary disease | $6834 | $535 | <0.0001 | −0.20 | 0.27 | 0.4705 |
Dementia | $33 724 | $1813 | <0.0001 | −1.23 | 0.84 | 0.1429 |
Paralysis | $55 342 | $2286 | <0.0001 | −0.36 | 1.05 | 0.7342 |
Liver disease | $4106 | $335 | <0.0001 | −0.14 | 0.16 | 0.3909 |
Ulcers | $14 085 | $939 | <0.0001 | −0.34 | 0.37 | 0.3586 |
Rheumatoid disease | $11 105 | $934 | <0.0001 | −0.63 | 0.42 | 0.1373 |
Unadjusted mean outcome during index year | $17 615 | 47.1 mmol/mol |
Coefficients in the total medical expenditure regression are in 2020 dollars. Coefficients in average HbA1c regression are in mmol/mol. The HbA1c sample includes person-years where an individual has at least one HbA1c test value during the year and is a subsample of the total medical expenditure sample.